Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders.
Antoine BabutyCamille DebordNicolas DrillaudMarion EveillardMarc TrossaërtCatherine TernisienMarianne SigaudEmmanuelle CadorMarie Christine BeneMarc FouassierPublished in: European journal of haematology (2023)
In this group of patients, there was an association between a pathological bleeding score and increased prothrombin consumption. This test could be used as an additional indicator of platelet function abnormality liable to be related to bleeding risk.